Nav: Home

Cellular senescence prevented by the SETD8 enzyme

March 08, 2017

An enzyme that blocks cellular senescence and its mechanisms has been discovered by a research team from Kumamoto University, Japan. They found that a reduction of the enzyme SETD8, which regulates cell proliferation and gene function, results in the promotion of cell aging features.

Many types of cells in the body eventually stop proliferation as their ability to divide decreases. This is called cellular senescence and is considered to be an important factor related to the aging process and life span. Although there are various etiologies of cellular senescence, the mechanism is still not well understood. In particular, stress-induced cellular senescence occurs when genomic DNA is damaged by physical factors, such as radiation, or by DNA-targeting chemicals. Additionally, when cells start becoming cancerous, cellular senescence occurs to prevent the onset of cancer. Unfortunately, increased age makes it easier to become sick, so it is important to properly control this particular cell function.

Senescent cells have a hypertrophied and flattened morphology, and lose their proliferative capacity. In recent years, it has been discovered that senescent cells secrete a variety of proteins which sometimes promote chronic inflammation as well as cancer development by acting on the surrounding cells. Since senescent cells are more active than expected, cellular senescence is considered to be the cause of the aging phenomena for the whole body. For example, it has been reported that when senescent cells of old mice are eliminated, whole body aging can be suppressed. In other words, if we can adjust cellular senescence, whole body aging may be controlled.

The team from Kumamoto University has been researching the mechanisms of cellular senescence from the viewpoint of epigenetics, a research field that studies the changes in gene expression by molecular modifications. They screened for factors related to the senescence of cultured human fibroblasts (cells in connective tissue which aid in cell proliferation, differentiation, and repair) by using various cell- and gene-mediated analyses. They discovered that the enzyme SETD8 methyltransferase, which adds methylation on histone H4 lysine 20 (H4K20), regulates senescent features.

Normal cells stop proliferation after dividing many times (replicative senescence), and when oncogenes are activated for cancer initiation, senescence occurs to prevent it (oncogene induced senescence). In the past, SETD8 was reported to regulate cell proliferation and gene function via H4K20 mono-methylation, but its relation to cellular senescence was unknown. The researchers, however, found that SETD8 decreased markedly in senescent cells. When they performed a gene knockdown experiment (using RNA interference) to suppress the function of SETD8 in fibroblasts, cellular senescence was induced with typical features. Furthermore, using a drug that inhibits the enzyme activity of SETD8, similar senescent cells appeared. In other words, SETD8 plays a role in preventing cellular senescence.

The researchers then comprehensively analyzed all gene expression in senescent cells with decreased SETD8. The results showed that the expression of genes involved in cellular senescence had increased, particularly the genes for ribosomal proteins and ribosomal RNAs responsible for cellular protein synthesis, and the genes of proteins that inhibit cell proliferation. This shows that a loss of SETD8 augments protein synthesis and growth arrest in senescent cells via gene regulation.

Senescent cells need large amounts of energy to maintain cellular functions such as protein synthesis and secretion. The researchers previously reported that energy production in mitochondria is markedly increased in senescent cells (Takebayashi et al. Aging Cell, 2015). Now, researchers have found that the activation of mitochondria is regulated by SETD8, and microscopic observations confirmed that the nucleolus and mitochondria were remarkably developed in SETD8 depleted cells. Therefore, cell senescence and its corresponding metabolic activities are promoted by a decrease in SETD8.

This research reveals that SETD8 protects against cellular senescence. It is expected that this result will be useful for understanding the mechanisms of senescence and developing a way to control cell aging.

This finding was first reported in Cell Reports on February 28th, 2017.
-end-
[Citation]

H. Tanaka, S.-i. Takebayashi, A. Sakamoto, T. Igata, Y. Nakatsu, N. Saitoh, S. Hino, and M. Nakao, "The setd8/pr-set7 methyltransferase functions as a barrier to prevent senescence-associated metabolic remodeling," Cell Reports, vol. 18, pp. 2148-2161, Feb. 2017. DOI: 10.1016/j.celrep.2017.02.021

Kumamoto University

Related Cancer Articles:

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
More Cancer News and Cancer Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...